Oxford Global are proud to present the prestigious Next Generation Sequencing & Single Cell Analysis Congress, taking place on 10 – 11 November 2016, London, UK. This highly established event will focus on key advancements in sequencing technologies, platforms as well as sequencing in the clinic and developments in NGS data analysis techniques. The single cell streams will cover single cell ‘omics case studies and therapeutic applications and overcoming the challenges in data analysis, bioinformatics and sample preparation.
To download the agenda, please click here: http://www.nextgenerationsequencing-congress.com/download-agenda
This congress will have 3 interactive streams:
The next generation sequencing market represents an advanced area of pharmaceutical research that is flourishing. Of particular interest is single cell analysis that is opening up new and exciting areas of observation.
Our highly distinguished event will bring together over 450 senior level delegates and will provide a unique opportunity to network with esteemed Professors and Directors from leading academic and research institutions, pharmaceutical companies such as UCL, University of Washington, Ghent University, Swiss Federal Institute of Technology and Novartis. Key presentations will include sequencing technologies and platforms for characterizing therapeutic producing cells by Nic Mermod, Professor, University of Lausanne and novel approaches for tagging endogenous genes and detection of their transcribed mRNAs by Yaron Shav-tal, Professor, Head – Dynamics of Gene Expression Lab, Bar-Ilan University.
The event will be co-located with the anticipated Genome Editing Congress covering novel genome editing techniques and therapeutic applications.
For the latest conference updates follow us on Twitter @xgenseq and join the event conversation on #xgenseq16. For more details on how to register for the meeting contact Danielle Dalby on firstname.lastname@example.org or call +44(0)1865 248455.
This content is blocked. Accept cookies to view the content.